Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Envoy Medical, Inc. - Class A Common Stock (NQ: COCH )

1.410 -0.040 (-2.76%)
Streaming Delayed Price Updated: 10:28 AM EDT, Apr 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,168
Open 1.420
Bid (Size) 1.410 (40)
Ask (Size) 1.510 (3)
Prev. Close 1.450
Today's Range 1.410 - 1.460
52wk Range 1.210 - 5.770
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Envoy Medical Reports Fourth Quarter and Full Year 2024 Financial Results
Company Provides Corporate Update that Includes Information on its Progress Enrolling Subjects in its Pivotal Clinical Study for Breakthrough Device,... 
Via Newsfile
Exposures Product Safety
Hearing Device Coverage Clarification Act Reintroduced in House and Senate
White Bear Lake, Minnesota--(Newsfile Corp. - March 17, 2025) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a revolutionary hearing... 
Via Newsfile

Performance

YTD
-8.44%
-8.44%
1 Month
-0.35%
-0.35%
3 Month
-7.24%
-7.24%
6 Month
-45.14%
-45.14%
1 Year
-72.73%
-72.73%

More News

Read More
Envoy Medical Secures $10 Million in Funding to Advance Pivotal Clinical Trial of Breakthrough Hearing Device
Via Newsfile
Envoy Medical to Participate in the 37th Annual ROTH Conference
Via Newsfile
First Two Participants Successfully Enrolled In Pivotal Clinical Study For Breakthrough Fully Implanted Cochlear Implant
Via Newsfile
Envoy Medical Secures Additional Patent Protection for Its Growing Patent Portfolio
Via Newsfile
Topics Intellectual Property
Exposures Intellectual Property
Envoy Medical Names Seven Investigational Sites for Participation in Its Pivotal Clinical Study
Via Newsfile
Exposures Product Safety
Envoy Medical Receives Additional Patent Protection for its Innovative Approach to Hearing Loss
From Envoy Medical, Inc
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Elastic Shares Are Trading Higher By 29%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Envoy Medical’s Fully Implanted Acclaim® Cochlear Implant Highlighted in Peer-Reviewed Publication
From Envoy Medical, Inc
Via GlobeNewswire
Envoy Medical Receives Another European Patent for its Modular Cochlear Implant System
From Envoy Medical, Inc
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Envoy Medical Receives FDA Approval To Initiate Pivotal Clinical Study for Breakthrough Hearing Device
From Envoy Medical, Inc
Via GlobeNewswire
Key Advocates Urge CMS to Clarify that Fully Implanted Active Middle Ear Hearing Devices are Prosthetic Devices for Purposes of Medicare Coverage
From Envoy Medical, Inc
Via GlobeNewswire
Envoy Medical to Present at the LD Micro Main Event XVII
From Envoy Medical, Inc
Via GlobeNewswire
American Medical Association Approves Groundbreaking New CPT Codes for Totally Implantable Active Middle Ear Hearing Implants Opening New Opportunities for Envoy Medical’s Esteem® Device
From Envoy Medical, Inc
Via GlobeNewswire
Envoy Medical Celebrates First Anniversary Trading as a Public Company under COCH on Nasdaq Capital Market
From Envoy Medical, Inc
Via GlobeNewswire
Major Envoy Medical Investor Glen Taylor Discusses How Apple’s AirPods Pro 2 Hearing Aid Announcement is a Potentially Positive Development for the Company
From Envoy Medical, Inc
Via GlobeNewswire
Envoy Medical Awarded Patent for Recharge System used with Implantable Battery
From Envoy Medical, Inc
Via GlobeNewswire
Hyliion Holdings And 2 Other Stocks Under $5 Executives Are Buying
Via Benzinga
Envoy Medical Secures Lending Facility of $10M
From Envoy Medical, Inc
Via GlobeNewswire
COCH Stock Earnings: Envoy Medical Misses EPS, Misses Revenue for Q2 2024
Via InvestorPlace
Bipartisan Senate Bill Seeks to Clarify that Implanted Active Middle Ear Hearing Devices are Prosthetics, Not Hearing Aids, Making Them Eligible for Medicare Coverage
From Envoy Medical, Inc
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.